Adherium Ltd has released a press release.
Adherium Smartinhaler in AstraZeneca COPD Study
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Adherium
- Clearance to Market in Canada for Flagship Products
- Appendix 4D and Interim Consolidated Financial Report
- Adherium Smartinhaler Technology in Multinational Study
- New Clinical Data Presented at ERS 2015
- Admission to Official List
Later from Adherium
- Adherium Executes Placement to Fidelity International
- Adherium and AstraZeneca Australia Commercial Pilot Program
- Key Technology Patent Granted in US
- Appendix 4C - quarterly for period ended 30 Sept 2016
- Adherium Smartinhaler dramatically improves outcomes
Follow Adherium into a list and get an email when it puts out news.
Follow Adherium